Phase II study of gefitinib as first-line chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations and poor prognostic characteristics.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e20625-e20625
Author(s):  
Shuji Murakami ◽  
Saki Manabe ◽  
Tetsuro Kondo ◽  
Haruhiro Saito ◽  
Kouzo Yamada
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Egfr Mutations ◽  
Small Cell Lung ◽  
First Line ◽  
Line Chemotherapy

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

2007 ◽  
Vol 60 (5) ◽  
pp. 725-732 ◽  
Author(s):  
Joaquín Casal ◽  
Margarita Amenedo ◽  
José Ramón Mel ◽  
Luis Miguel Antón ◽  
Rubén Rodríguez-López ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document